1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic UrticariaChronic Disease, Disease Attributes, Hypersensitivity, Immediate, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, Urticaria, Solar, chronic inducible urticaria, chronic urticaria, cold urticaria, familial dermatographia, immune system disorder, photosensitivity disease, skin disorder, skin vascular disease, urticariaRecruitingPhase 22026-09-28NCT06865651